drugset / Trial / NCT06173869
A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a phase 3b clinical trial with follitropin delta (FE 999049) and Gonal-F. The trial is a randomised, controlled, assessor-blind, parallel groups, multicentre trial comparing the ovarian response of a starting dose of either 10mg or 15 mg follitropin delta to a starting dose of either 150 IU or 225 IU Gonal-F in a long GnRH agonist protocol in women undergoing an assisted reproductive technology programme in China.
Timeline
- Start
- 2024-03-29
- Primary completion
- 2025-05-31
- Completion
- 2025-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Follitropin delta | Protein / enzyme biologic | 10 ug | Subcutaneous |
| Subject | Follitropin delta | Protein / enzyme biologic | 15 ug | Subcutaneous |
| Comparator | Gonal-f | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Comparator | Gonal-f | Protein / enzyme biologic | 225 iu | Subcutaneous |